KRAS and cancer: In oncogene mutated cancers like KRASG12D-driven PDAC (Pancreatic Ductal Adenocarcinoma) and MYC/KRAS or MYC/ERBB2-ablated breast cancer, cancer cells predominantly rely on OXPHOS for energy production [17].